191 related articles for article (PubMed ID: 7521454)
1. Effects of a novel cardiotonic agent (+-)-6-[3-(3,4-dimethoxybenzylamino)-2-hydroxypropoxy]-2(1H)-quinolino ne (OPC-18790) on contractile force, cyclic AMP level, and aequorin light transients in dog ventricular myocardium.
Endoh M; Kawabata Y; Katano Y; Norota I
J Cardiovasc Pharmacol; 1994 May; 23(5):723-30. PubMed ID: 7521454
[TBL] [Abstract][Full Text] [Related]
2. Effects of a novel cardiotonic agent, Org 9731, on force and aequorin light transients in intact ventricular myocardium of the dog: involvement of a cyclic AMP-mediated mechanism and myofibrillar responsiveness to Ca2+ ions.
Kawabata Y; Endoh M
J Card Fail; 1995 Mar; 1(2):143-53. PubMed ID: 9420644
[TBL] [Abstract][Full Text] [Related]
3. Effects of new inotropic agents on cyclic nucleotide metabolism and calcium transients in canine ventricular muscle.
Endoh M; Yanagisawa T; Taira N; Blinks JR
Circulation; 1986 Mar; 73(3 Pt 2):III117-33. PubMed ID: 2417745
[TBL] [Abstract][Full Text] [Related]
4. Subcellular mechanism of the positive inotropic effect of a new quinolinone derivative OPC-8490 on the dog ventricular myocardium.
Endoh M; Satoh H; Norota I; Hirano K; Hosokawa T
Heart Vessels; 1991; 6(3):158-67. PubMed ID: 1655692
[TBL] [Abstract][Full Text] [Related]
5. Effects of the positive inotropic agent Org 30029 on developed force and aequorin light transients in intact canine ventricular myocardium.
Kawabata Y; Endoh M
Circ Res; 1993 Mar; 72(3):597-606. PubMed ID: 8431987
[TBL] [Abstract][Full Text] [Related]
6. Regulation of force and intracellular calcium transients by cyclic AMP generated by forskolin, MDL 17,043 and isoprenaline, and its modulation by muscarinic receptor agents: a novel mechanism for accentuated antagonism.
Endoh M
Basic Res Cardiol; 1989; 84 Suppl 1():69-83. PubMed ID: 2554874
[TBL] [Abstract][Full Text] [Related]
7. Effects of levosimendan on myocardial contractility and Ca2+ transients in aequorin-loaded right-ventricular papillary muscles and indo-1-loaded single ventricular cardiomyocytes of the rabbit.
Sato S; Talukder MA; Sugawara H; Sawada H; Endoh M
J Mol Cell Cardiol; 1998 Jun; 30(6):1115-28. PubMed ID: 9689586
[TBL] [Abstract][Full Text] [Related]
8. Involvement of cyclic AMP in the positive inotropic effect of OPC-8212, a new cardiotonic agent, on the canine ventricular muscle.
Yanagisawa T; Endoh M; Taira N
Jpn J Pharmacol; 1984 Nov; 36(3):379-88. PubMed ID: 6097725
[TBL] [Abstract][Full Text] [Related]
9. Effects of a cardiotonic quinolinone derivative Y-20487 on the isoproterenol-induced positive inotropic action and cyclic AMP accumulation in rat ventricular myocardium: comparison with rolipram, Ro 20-1724, milrinone, and isobutylmethylxanthine.
Katano Y; Endoh M
J Cardiovasc Pharmacol; 1992; 20(5):715-22. PubMed ID: 1280732
[TBL] [Abstract][Full Text] [Related]
10. Effects of a new cardiotonic agent 1,2-dihydro-6-methyl-2-oxo-5-[imidazo (1,2-a) pyridin-6-yl]-3-pyridine carbonitrile hydrochloride monohydrate (E-1020) on contractile force and cyclic AMP metabolism in canine ventricular muscle.
Satoh H; Endoh M
Jpn J Pharmacol; 1990 Feb; 52(2):215-24. PubMed ID: 2156096
[TBL] [Abstract][Full Text] [Related]
11. Pharmacological characterization of effects of UK-1745, a novel cardiotonic agent with beta-adrenoceptor-blocking action, in aequorin-loaded canine right ventricular muscle.
Sawada H; Endoh M
J Mol Cell Cardiol; 1999 May; 31(5):1047-62. PubMed ID: 10336843
[TBL] [Abstract][Full Text] [Related]
12. The effects of theophylline on aequorin light transients and force in the isolated dog right ventricular myocardium.
Endoh M
J Mol Cell Cardiol; 1994 Jan; 26(1):87-98. PubMed ID: 8196072
[TBL] [Abstract][Full Text] [Related]
13. Cardiovascular actions of OPC-18790: a novel positive inotropic agent with little chronotropic action.
Hosokawa T; Mori T; Fujiki H; Kinoshita S; Takemoto K; Imaizumi T; Noda T; Ohura M; Tominaga M; Yabuuchi Y
Heart Vessels; 1992; 7(2):66-75. PubMed ID: 1328145
[TBL] [Abstract][Full Text] [Related]
14. The effects of milrinone and piroximone on intracellular calcium handling in working myocardium from the ferret.
Gwathmey JK; Morgan JP
Br J Pharmacol; 1985 May; 85(1):97-108. PubMed ID: 2992656
[TBL] [Abstract][Full Text] [Related]
15. Dual regulation of myofilament Ca2+ sensitivity by levosimendan in normal and acidotic conditions in aequorin-loaded canine ventricular myocardium.
Takahashi R; Endoh M
Br J Pharmacol; 2005 Aug; 145(8):1143-52. PubMed ID: 15951828
[TBL] [Abstract][Full Text] [Related]
16. Abnormal intracellular calcium handling, a major cause of systolic and diastolic dysfunction in ventricular myocardium from patients with heart failure.
Morgan JP; Erny RE; Allen PD; Grossman W; Gwathmey JK
Circulation; 1990 Feb; 81(2 Suppl):III21-32. PubMed ID: 2153479
[TBL] [Abstract][Full Text] [Related]
17. Effects of a new 1,3-thiazole derivative ZSY-39 on force of contraction and cyclic AMP content in canine ventricular muscle.
Endoh M; Satoh H; Norota I; Hirano K
Cardiovasc Drugs Ther; 1990 Aug; 4(4):1127-34. PubMed ID: 1964579
[TBL] [Abstract][Full Text] [Related]
18. Positive inotropic and negative chronotropic effects of OPC-8490, a newly developed cardiotonic, in isolated, blood-perfused canine heart preparations.
Furukawa Y; Akahane K; Haniuda M; Chiba S
Jpn Heart J; 1989 May; 30(3):387-98. PubMed ID: 2552190
[TBL] [Abstract][Full Text] [Related]
19. The effects of various drugs on the myocardial inotropic response.
Endoh M
Gen Pharmacol; 1995 Jan; 26(1):1-31. PubMed ID: 7713348
[TBL] [Abstract][Full Text] [Related]
20. Changes in intracellular Ca2+ mobilization and Ca2+ sensitization as mechanisms of action of physiological interventions and inotropic agents in intact myocardial cells.
Endoh M
Jpn Heart J; 1998 Jan; 39(1):1-44. PubMed ID: 9601480
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
